Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

IDATvsIHE

iShares Cloud 5G and Tech ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
Head to head
IDATIHE
Expense ratio0.47%0.37%
Assets$9M$1.7B
Net flow, 1 month—+$49M
Net flow, 1 year—+$722M
Return, YTD—+29.2%
Return, 1 year——
Avg daily volume—270K
Holdings4852
ListedJun 8, 2021May 1, 2006
Options marketNoYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.